Scientists just took a big, “very positive” step towards developing what could be the first ‘universal cancer vaccine’.
The results from early trials in humans, along with research in mice, have just been published, and they suggest that the new technique could be used to activate patients’ immune systems against any type of tumour, no matter where it is in the body.
Unlike the vaccines we’re familiar with, this potential vaccine would be given to patients who already have cancer, rather than those at risk of getting it. It basically works by shooting tiny ‘darts’ containing pieces of RNA extracted from the patient’s cancer cells at the body’s own immune system, convincing them to launch an all-out attack on any tumours they come across.
By just changing the RNA inside those darts, the team can, in theory, mobilise the immune system against any kind of cancer. “[Such] vaccines are fast and inexpensive to produce, and virtually any tumour antigen can be encoded by RNA,” the team, led by researchers at Johannes Gutenberg University of Mainz in Germany, reports in Nature.
“Thus, the nanoparticulate RNA immunotherapy approach introduced here may be regarded as a universally applicable novel vaccine class for cancer immunotherapy.”
Immunotherapy, which involves using the patient’s own immune system to attack cancer, isn’t in itself new – researchers are already using it against different cancer types with great results.
But until now, researchers have mostly done this by genetically engineering special, cancer-targeting immune cells in the lab, and then injecting them back into a patient – which is a time-consuming and expensive process.
The difference with this technique is that the vaccine is made in the lab, and it introduces the cancer DNA into the immune cells within the body, which is a lot less invasive. It also means that the vaccine can be tweaked to hunt a range of cancer types.
Learn more: Scientists have performed the first trials of a ‘universal cancer vaccine’
The Latest on: Universal cancer vaccine
[google_news title=”” keyword=”universal cancer vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Universal cancer vaccine
- Could Cancer Vaccines Be the Next Big Breakthrough in Immunotherapy?on May 12, 2024 at 9:34 pm
The race is on to develop therapeutic cancer vaccines that could give immunotherapies an edge, and late-stage trials could soon provide more-robust data about candidates’ efficacy and safety.
- Calls for a concerted drive towards SDGson May 11, 2024 at 1:46 pm
Results Report 2023, the most comprehensive to date, showcases the achievement of key public health milestones, even amid greater global humanitarian health needs driven by conflict, climate change, ...
- Cancer Vaccine Triggers Fierce Immune Response to Fight Malignant Brain Tumors in Human Patientson May 11, 2024 at 6:37 am
In the first human trial, an mRNA cancer vaccine at the University of Florida triggered immune systems to fiercely attack glioblastoma.
- Moderna Stock Slips as FDA Delays RSV Vaccine Approvalon May 10, 2024 at 8:59 am
Moderna shares fell in intraday trading Friday as it said the FDA has pushed back its RSV vaccine approval decision until the end of the month.
- Revolutionary mRNA Cancer Vaccine Shows Immense Promise in First-Ever Human Clinical Trialon May 10, 2024 at 8:56 am
In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine created at the University of Florida rapidly reprogrammed the immune system to target glioblastoma, the deadliest ...
- New mRNA vaccine for deadly brain cancer triggers a strong immune responseon May 9, 2024 at 4:00 am
COVID-19 vaccine development paves way to a new class of cancer immunotherapy. For the first time, scientists have tested a messenger RNA (mRNA) vaccine in a patient with a deadly form of brain cancer ...
- Research aims to develop vaccine against future COVID viruseson May 6, 2024 at 7:48 am
Scientists are busy working on a vaccine that might fight strains of the COVID virus SARS-CoV-2 that haven't even emerged yet.
- Vaccine, not condoms, can prevent sexually transmitted canceron May 4, 2024 at 12:00 am
such as cancer of the oesophagus, colon, rectum, liver, urinary bladder, head and neck, liver, anus and gastric tumours, all of which occur in both males and females. Bivalent vaccine is effective ...
- MIT Technology Reviewon May 3, 2024 at 2:59 am
But the burst of renewed interest and activity around cancer vaccines is encouraging. And personalized vaccines might have a shot at succeeding where others have failed. The strategy makes sense for ...
- New mRNA Vaccines in Development for Cancer and Infectionson May 2, 2024 at 2:22 am
Prelog also discussed personalized vaccines for cancer immunotherapy. Personalized mRNA vaccines are tailored to the patient's genetic characteristics and antigens. They could be used in cancer ...
via Bing News